R Squared LTD Voyager Therapeutics, Inc. Transaction History
R Squared LTD
- $181 Billion
- Q2 2025
A detailed history of R Squared LTD transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, R Squared LTD holds 15,488 shares of VYGR stock, worth $48,632. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,488Holding current value
$48,632% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding VYGR
# of Institutions
124Shares Held
34.6MCall Options Held
12.9KPut Options Held
37.7K-
Armistice Capital, LLC New York, NY5.44MShares$17.1 Million0.28% of portfolio
-
Black Rock Inc. New York, NY5.31MShares$16.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$12.3 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$10.1 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.57MShares$8.07 Million0.05% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $121M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...